Development of health technology assessment in Lithuania.
نویسنده
چکیده
OBJECTIVES To describe how Lithuania is attempting to develop health technology assessment (HTA) structures. METHODS The case study of the history of development of HTA in Lithuania is presented. RESULTS Historical steps of HTA development are as follows: in 1993, a few conferences on HTA; eight people were trained in Sweden at SBU; the book First Steps of HTA in Lithuania (5) was issued together with SBU in 1993; participation in the International Society of Technology Assessment in Health Care (ISTAHC) conferences; participation in development of training courses and European networks of HTA; new people in HTA were trained in health accreditation service, Sickness Fund, and Ministry of Health. The major step was establishment of an evidence-based medicine library. In 1994, Article 54 in the Health Care System Law, which declares that the use of healthcare technologies that have not been assessed or approved shall be prohibited, except in cases provided by law, was passed. The procedure of healthcare technologies assessment and approval was to be established by the Ministry of Health Care. A policy of HTA was approved with the program for HTA in 1999 in the Ministry of Health. Currently, enthusiasts of HTA fully realize that technology assessment is a developing frontier for creative and constructive thinking from all disciplinary view points. CONCLUSIONS Unfortunately, in this country, there is still a very small demand for HTA reports from the decision-maker's side. Hopefully joining the network of European Union Network for Health Technology Assessment (EUnetHTA) will give a new challenge for further policy development.
منابع مشابه
Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed?; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
A recent paper by Grutters et al makes the case for early health economic modeling in the development of health technologies. A number of examples of the value of early modeling are given, with analyses being performed at different stages in the development of several non-drug health technologies. This commentary acknowledges the contribution of the paper by Grutters et...
متن کاملThe Bright Elusive Butterfly of Value in Health Technology Development; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
The current system of health technology development is characterised by multiple misalignments. The “supply” side (innovation policy-makers, entrepreneurs, investors) and the “demand” side (health policy-makers, regulators, health technology assessment, purchasers) operate under different – and conflicting – logics. The system is less a “pathway” than an unstable ecosystem of multiple interacti...
متن کاملInvolvement of Patients in Health Technology Assessment: Further Perspectives for Informing Decision-Makers
Health technology assessment (HTA) is an evaluative process used to inform technology-related policymaking in healthcare. Interest in involving patients in the HTA process is increasing. Patients can provide additional perspectives to those of other groups that are concerned with health technology. Information on patients’ perspectives is preferably obtained through reviews of published studies...
متن کاملPrevalence of Gram Positive Bacteria in Cow Mastitis and Their Susceptibility to Beta-lactam Antibiotics
Irena Klimienė, Modestas Ružauskas, Vytautas Špakauskas, Raimundas Mockeliūnas, Asta Pereckienė, Česlova Butrimaitė-Ambrozevičienė Veterinary Institute, Veterinary Academy of Lithuanian University of Health Sciences Tilžės str. 18, LT-47181 Kaunas, Lithuania; e-mail: [email protected] Department of Non-Infectious Diseases, Veterinary Academy, Lithuanian University of Health Sciences Tilžes st...
متن کاملHealth Technology Assessment: Global Advocacy and Local Realities; Comment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness”
Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, however, and countries often begin by demanding evidence (including local CEA evidence as well as evi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- International journal of technology assessment in health care
دوره 25 Suppl 1 شماره
صفحات -
تاریخ انتشار 2009